MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.
Saved in:
| Title: | MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection. |
|---|---|
| Authors: | Rozanov DV; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, United States. Electronic address: rozanov@ohsu.edu., Rozanov ND; Oregon State University, Corvallis, OR, United States., Chiotti KE; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, United States., Reddy A; Proteomics Shared Resource, Oregon Health and Science University, Portland, OR, United States., Wilmarth PA; Proteomics Shared Resource, Oregon Health and Science University, Portland, OR, United States., David LL; Proteomics Shared Resource, Oregon Health and Science University, Portland, OR, United States., Cha SW; Electrical and Computer Engineering, University of California, San Diego, CA, United States., Woo S; School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Pevzner P; The NIH Center for Computational Mass Spectrometry, University of California, San Diego, San Diego, CA, United States., Bafna V; Computer Science & Engineering, University of California, San Diego, CA, United States., Burrows GG; Neurology and Biochemistry & Molecular Biology, Oregon Health and Science University, Portland, OR, United States., Rantala JK; Misvik biology Ltd, Turku, Finland., Levin T; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, United States., Anur P; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, United States., Johnson-Camacho K; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, United States., Tabatabaei S; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, United States., Munson DJ; Department of Immunology & Microbiology, University of Colorado, Denver, CO, United States., Bruno TC; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, United States., Slansky JE; Department of Immunology & Microbiology, University of Colorado, Denver, CO, United States., Kappler JW; National Jewish Medical and Research Center, Denver, CO, United States., Hirano N; Margaret Cancer Centre, Toronto, Ontario, Canada., Boegel S; University Medical Center, Johannes Gutenberg-University, Mainz, Germany., Fox BA; Laboratory of Molecular and Tumor Immunology, Chiles Research Institute Providence PDX Medical Center, Portland, OR, United States., Egelston C; City of Hope National Medical Center, Duarte, CA, United States., Simons DL; City of Hope National Medical Center, Duarte, CA, United States., Jimenez G; City of Hope National Medical Center, Duarte, CA, United States., Lee PP; City of Hope National Medical Center, Duarte, CA, United States., Gray JW; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, United States; Center for Health & Healing, Oregon Health and Science University, Portland, OR, United States., Spellman PT; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, United States. |
| Source: | Journal of proteomics [J Proteomics] 2018 Mar 30; Vol. 176, pp. 13-23. Date of Electronic Publication: 2018 Jan 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101475056 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7737 (Electronic) Linking ISSN: 18743919 NLM ISO Abbreviation: J Proteomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
